These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 8061479)

  • 1. Sublingual nifedipine: the continuing controversy.
    Oliver S
    Aust Crit Care; 1994 Jun; 7(2):12-4. PubMed ID: 8061479
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nifedipine serum concentrations following sublingual and oral doses.
    Brown GR; Fraser DG; Castile JA; Gaudreault P; Platt DR; Friedman PA
    Int J Clin Pharmacol Ther Toxicol; 1986 Jun; 24(6):283-6. PubMed ID: 3733277
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative study of buccoadhesive formulations and sublingual capsules of nifedipine.
    Save T; Shah MU; Ghamande AR; Venkitachalam P
    J Pharm Pharmacol; 1994 Mar; 46(3):192-5. PubMed ID: 8027926
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetics and pharmacodynamics of two commercial oral nifedipine products.
    Shaheen O; Zmeili S; al-Qussuois Y; Arafat T; Mouti H
    Int J Clin Pharmacol Ther Toxicol; 1991 Sep; 29(9):337-41. PubMed ID: 1937993
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetic and pharmacodynamic comparisons of oral and sublingual nifedipine in hypertensive Mexican patients.
    Palma-Aguirre JA; Roa-Mendieta A; Hernández-Jiménez LM; Girard-Cuesy ME; León-Urrea F; Alfaro-Mejía A; Frati A; Barreiro-Perera O
    Proc West Pharmacol Soc; 1993; 36():137-41. PubMed ID: 8378367
    [No Abstract]   [Full Text] [Related]  

  • 6. Bioavailability and pharmacokinetics of nifedipine administered by different routes in healthy volunteers.
    Palma-Aguirre JA; Rosas-Alcázar G; Rodríguez JM; León-Urrea F; Montoya-Cabrera MA
    Arch Invest Med (Mex); 1989; 20(2):129-35. PubMed ID: 2604495
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Negligible sublingual absorption of nifedipine.
    van Harten J; Burggraaf K; Danhof M; van Brummelen P; Breimer DD
    Lancet; 1987 Dec; 2(8572):1363-5. PubMed ID: 2890954
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of the method for nifedipine administration for a rapid onset of clinical effect: a clinical study in normal volunteers.
    Kubota R; Komiyama T; Shimada H
    Yakugaku Zasshi; 2001 May; 121(5):355-64. PubMed ID: 11360489
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Kinetics and dynamics of nifedipine after oral and sublingual doses.
    McAllister RG
    Am J Med; 1986 Dec; 81(6A):2-5. PubMed ID: 3799661
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Haemodynamic effects of combined oral nifedipine and sublingual nitroglycerin in patients with chronic stable angina.
    Boje KM; Fung HL; Yoshitomi K; Parker JO
    Eur J Clin Pharmacol; 1987; 33(4):349-54. PubMed ID: 3127220
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of sublingual captopril and sublingual nifedipine in hypertensive emergencies.
    Ceyhan B; Karaaslan Y; Caymaz O; Oto A; Oram E; Oram A; Ugurlu S
    Jpn J Pharmacol; 1990 Feb; 52(2):189-93. PubMed ID: 2179605
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of sublingual captopril, nifedipine and prazosin in hypertensive emergencies during hemodialysis.
    Wu SG; Lin SL; Shiao WY; Huang HW; Lin CF; Yang YH
    Nephron; 1993; 65(2):284-7. PubMed ID: 8247194
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Efficacy and safety of low dose sublingual nifedipine dripping pills (5 mg) in the acute treatment of moderate and severe hypertension: a randomized, double-blind, positive-drug parallel-controlled, multi-center clinical study].
    Liu JH; Han YL; Zhang SY; Wei Y; Li ZQ; Wang YK; Qing Y; Huang Y; Chen XP; Chen XM; Wang H; Li YJ; Mo YQ; Wu DM; Liang KS
    Zhonghua Xin Xue Guan Bing Za Zhi; 2019 May; 47(5):374-380. PubMed ID: 31142081
    [No Abstract]   [Full Text] [Related]  

  • 14. Sublingual nifedipine controversy in drug delivery.
    Schumann D
    Dimens Crit Care Nurs; 1991; 10(6):314-20. PubMed ID: 1935527
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relative bioavailability of four controlled-release nifedipine products.
    Schall R; Müller FO; Hundt HK; Duursema L; Groenewoud G; Van Dyk M; Van Schalkwyk AM
    Biopharm Drug Dispos; 1994 Aug; 15(6):493-503. PubMed ID: 7993987
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of sublingual nifedipine on coronary venous graft resistance immediately following cardiopulmonary bypass.
    Eide TR; Katz RI; Poppers PJ
    Anesth Analg; 1989 Apr; 68(4):462-6. PubMed ID: 2929979
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sublingual nicardipine versus nifedipine to treat hypertensive urgencies.
    Savi L; Montebelli MR; D'Alonzo S; Mettimano M; Folli G
    Int J Clin Pharmacol Ther Toxicol; 1992 Feb; 30(2):41-5. PubMed ID: 1551744
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of sublingual captopril and nifedipine in immediate treatment of hypertensive emergencies. A randomized, single-blind clinical trial.
    Angeli P; Chiesa M; Caregaro L; Merkel C; Sacerdoti D; Rondana M; Gatta A
    Arch Intern Med; 1991 Apr; 151(4):678-82. PubMed ID: 2012448
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The use of sublingual nifedipine in pediatric hypertensive patients at the Hospital de la Capital].
    Marrero Arroyo D; Carrer MT; Molina M; Gómez M; Jiménez E
    Bol Asoc Med P R; 1991 Dec; 83(12):530-4. PubMed ID: 1811604
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Nifedipine level in the blood and its immediate hypotensive effect after its sublingual administration to aged patients].
    Kawecka-Jaszcz K; Grodzicki T; Skoczeń M; Czarnecka D; Gryglewska B; Dubiel JP; Kocemba J; Witek J
    Przegl Lek; 1989; 46(2):311-5. PubMed ID: 2772233
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.